• Patient 1 of Cohort 1 has now completed the 24-month follow-up timepoint, and at month-24 post-treatment Patient 1 continued to demonstrate the powerful disease-modifying effects of BB-301, with ...

A new Consumer Analysis investigates the SleepZee Mouth Guard, examining the moldable anti-snoring device's published specifications, material composition claims, and company disclosure practices as ...

Critical Clarification: This is ingredient-level research only. NutriDerma Guard as a finished commercial product has not been independently clinically studied in published peer-reviewed trials.

The phrases "best GLP-1 patch," "natural Ozempic alternative," and "berberine weight loss patch" are used in this report to reflect common consumer search behavior and category language. GLP-1 ...

Under the agreement, Etienna Bio has obtained exclusive global rights to intellectual property covering human adipose-derived progenitor cells combined with an adipose-derived hydrogel matrix, ...

COPENHAGEN, Denmark, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today provided a business and strategic roadmap update, including planned 2026 key corporate milestones.

Transdermal berberine patches represent an emerging supplement format driven by consumer interest in convenience and non-pill delivery. While ingredient-level research on berberine and chromium exists ...

The phrase "anti-snoring mouthpiece vs nose strips" is used to reflect common consumer search behavior. This report does not rank products, recommend purchases, or predict individual outcomes. The ...

Strong balance sheet with cash, cash equivalents, and marketable securities of $208.9 million*, including proceeds from the equity financing, which is anticipated to close on January 13, 2026, and ...

WINNIPEG, Jan. 09, 2026 (GLOBE NEWSWIRE) -- The Canadian Red Cross has launched the 2026 Pimicikamak Cree Nation Crisis Appeal to provide support for those impacted by the power outage in Pimicikamak ...

According to Health Journey, GLP-1 Booster is a dietary supplement containing a probiotic blend designed to support gut health. The company states that the product is manufactured in a GMP-certified ...

Morgan Stanley, Leerink Partners, Cantor and Wells Fargo Securities acted as joint book-running managers for the offering. Baird and Oppenheimer & Co. acted as co-lead managers for the offering.